This digital event will help labs meet the various legal, compliance, business, and technology challenges of the industry, today and tomorrow.
With threats and attacks increasing, Congress has tabled a bill that would impose extra penalties on those seeking to harm healthcare staff.
Researchers propose solutions to underrepresentation of certain groups in genetic databases, based on two recent initiatives.
Guidance from the American College of Medical Genetics and Genomics shares the importance of a genetic evaluation for hearing loss.
This free webinar addresses annual billing changes and critical developments currently facing laboratory medicine.
As of October 1, medical device makers must include information about their products’ vulnerabilities when seeking premarket authorization.
This session will offer an understanding of the Cures Act, as well as responsibilities and opportunities available to laboratories as a result of the law.
When it comes to protected health information, it’s important that labs manage contracts with external sources to ensure HIPAA compliance.
Privacy in the Post Roe v. Wade World: How Could Proposed HIPAA Restrictions on Reproductive PHI Affect Labs?
Key points labs should know about the recently proposed OCR rule on privacy protections for PHI associated with reproductive health care.
An analysis of recent OCR enforcement actions and settlements identifies the common pitfalls labs should watch out for.
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.
Using LIMS and no-code solutions can unlock opportunities for efficiency.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.